tradingkey.logo
搜尋

ASP Isotopes Inc

ASPI
添加自選
4.011USD
0.0000.00%
交易中 美東報價延遲15分鐘
505.00M總市值
虧損本益比TTM

關於 ASP Isotopes Inc 公司

ASP Isotopes Inc. is a development stage advanced materials company. The Company is engaged in the development of technology and processes to produce isotopes for use in multiple industries. The Company employs proprietary technology, the Aerodynamic Separation Process (ASP technology). Its initial focus is on producing and commercializing highly enriched isotopes for the healthcare and technology industries. Its Nuclear Fuels segment is focused on research and development of technologies and methods used to produce high-assay low-enriched uranium (HALEU) and Lithium-6 for the advanced nuclear fuels target end market. Its Specialist Isotopes and Related Services segment is focused on research and development of technologies and methods used to separate high-value, low-volume isotopes (such as C-14, Mo-100, and Si-28) for highly specialized target end markets other than advanced nuclear fuels, including pharmaceuticals and agrochemicals, nuclear medical imaging, and others.

ASP Isotopes Inc簡介

公司代碼ASPI
公司名稱ASP Isotopes Inc
上市日期Nov 10, 2022
CEOAinscow (Robert)
員工數量136
證券類型Ordinary Share
年結日Nov 10
公司地址601 Pennsylvania Avenue Nw
城市WASHINGTON
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編20004
電話12027562245
網址https://aspisotopes.com/
公司代碼ASPI
上市日期Nov 10, 2022
CEOAinscow (Robert)

ASP Isotopes Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board
Executive Chairman of the Board
9.58M
-2.62%
Mr. Robert Ainscow
Mr. Robert Ainscow
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
2.28M
-0.37%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
1.53M
-1.52%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
1.04M
-1.11%
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
672.25K
-14.88%
Mr. Donald G. Ainscow
Mr. Donald G. Ainscow
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
400.00K
-25.00%
Prof. Michael (Mike) Gorley, Ph.D.
Prof. Michael (Mike) Gorley, Ph.D.
Independent Director
Independent Director
87.91K
-34.13%
Mr. Sipho Nkosinathi Maseko
Mr. Sipho Nkosinathi Maseko
Independent Director
Independent Director
58.97K
+61.98%
Dr. Hendrik Strydom, Ph.D.
Dr. Hendrik Strydom, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Mr. Robert Ryan
Mr. Robert Ryan
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Paul Elliot Mann
Mr. Paul Elliot Mann
Executive Chairman of the Board
Executive Chairman of the Board
9.58M
-2.62%
Mr. Robert Ainscow
Mr. Robert Ainscow
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
Interim Chief Executive Officer, Co-Founder, Chief Operating Officer
2.28M
-0.37%
Ms. Heather Kiessling
Ms. Heather Kiessling
Chief Financial Officer
Chief Financial Officer
1.53M
-1.52%
Dr. Duncan Moore, Ph.D.
Dr. Duncan Moore, Ph.D.
Independent Director
Independent Director
1.04M
-1.11%
Dr. Todd Wider, M.D.
Dr. Todd Wider, M.D.
Independent Director
Independent Director
672.25K
-14.88%
Mr. Donald G. Ainscow
Mr. Donald G. Ainscow
Executive Vice President, General Counsel, Company Secretary
Executive Vice President, General Counsel, Company Secretary
400.00K
-25.00%

常見問題

ASP Isotopes Inc的前五大股東是誰?

ASP Isotopes Inc的前五大股東如下:Mr. Paul Elliot Mann

有多少機構持有ASP Isotopes Inc(ASPI)的股份?

截至2026Q1,共有345家機構持有ASP Isotopes Inc的股份,合計持有的股份價值約為73.95M,占公司總股份的58.74% 。與2025Q4相比,機構持股有所增加,增幅為11377644.00。
tradingkey.logo
風險提示:我們的網站和行動應用程式僅提供關於某些投資產品的一般資訊。Finsights 不提供財務建議或對任何投資產品的推薦,且提供此類資訊不應被解釋為 Finsights 提供財務建議或推薦。
投資產品存在重大投資風險,包括可能損失投資的本金,且可能並不適合所有人。投資產品的過去表現並不代表其未來表現。
Finsights 可能允許第三方廣告商或關聯公司在我們的網站或行動應用程式的任何部分放置或投放廣告,並可能根據您與廣告的互動情況獲得報酬。
© 版權所有: FINSIGHTS MEDIA PTE. LTD. 版權所有